LMAT FINANCIAL STATEMENTS

LeMaitre Vascular Inc — balance sheet, income statement and cash flow trends

LMATLeMaitre Vascular Inc

🇺🇸 USA · NASDAQ · Healthcare · Medical Instruments & Supplies

Value it Duel

Income Statement

Quarterly progression — trailing-twelve-month values

RevenueNet Income

Profit Funnel

Q1 2026 · TTM

Percentages are relative to revenue.

Key Figures

YoY change

Revenue256.3 M $+13.3%

Gross Profit185.5 M $+19.2%

Operating Income73.1 M $+37.8%

EBITDA96.3 M $+31.7%

Net Income62.4 M $+38.2%

Peer Comparison· Medical Instruments & Supplies

Company	Rev. Growth	Gross Margin	EBITDA Margin	Net Margin
LMAT	13.3%	72.4%	37.6%	24.3%
ANN	11.4%	41.9%	15.2%	6.7%
FPH	4.8%	64.2%	34.9%	20.0%
RMD	10.5%	61.2%	39.1%	27.4%
CTEC	6.8%	55.8%	25.3%	7.2%
EL	7.5%	60.6%	23.0%	8.1%
Industry median	6.4%	53.7%	13.8%	3.9%

Company	Rev. Growth	Gross Margin	EBITDA Margin	Net Margin
LMAT	13.3%	72.4%	37.6%	24.3%
XRAY	-1.0%	48.9%	-3.5%	-17.1%
PLSE	-69.9%	-91.1%	-9,866.7%	-9,929.0%
ATRC	15.0%	75.5%	4.5%	-0.8%
WRBY	12.0%	53.4%	6.1%	0.2%
ICUI	-10.9%	36.4%	12.2%	2.1%
Industry median	6.4%	53.7%	13.8%	3.9%

Balance Sheet

Quarterly period-end values

Total AssetsTotal LiabilitiesEquity

Capital Structure

Q1 2026

Equity406.6 M $65%
Current Liabilities33.4 M $5%
Long-term Liabilities189.5 M $30%

Key Figures

YoY change

Total Assets629.5 M $+13.2%

Total Liabilities222.9 M $+6.9%

Total Equity406.6 M $+17.0%

Cash & ST Investments367.2 M $+21.4%

Total Debt189.8 M $+2.4%

Net Debt163 M $+1.8%

Peer Comparison· Medical Instruments & Supplies

Company	Current Ratio	Debt/Equity	NetDebt/EBITDA	Equity/Assets
LMAT	14.32	46.7%	-1.84	64.6%
ANN	2.36	46.2%	2.10	59.3%
FPH	2.31	6.9%	-0.39	74.1%
RMD	3.01	13.0%	-0.38	73.9%
CTEC	1.53	100.0%	2.33	40.1%
EL	0.99	37.0%	1.66	60.9%
Industry median	2.40	34.8%	1.44	62.7%

Company	Current Ratio	Debt/Equity	NetDebt/EBITDA	Equity/Assets
LMAT	14.32	46.7%	-1.84	64.6%
XRAY	1.53	176.9%	-16.86	25.2%
PLSE	7.26	10.8%	0.83	81.2%
ATRC	4.29	15.2%	-2.88	76.4%
WRBY	2.33	63.2%	-0.94	51.0%
ICUI	2.30	63.5%	4.01	52.6%
Industry median	2.40	34.8%	1.44	62.7%

Cash Flow Statement

Quarterly progression — trailing-twelve-month values

Operating Cash FlowCapital ExpendituresFree Cash Flow

Cash Flow Bridge

Q1 2026 · TTM

Key Figures

YoY change

Operating Cash Flow87.3 M $+81.5%

Capital Expenditures8.2 M $+17.3%

Free Cash Flow79.1 M $+92.4%

Dividends Paid-19.3 M $-226.1%

Peer Comparison· Medical Instruments & Supplies

Company	CF Margin	FCF Margin	CapEx Ratio	CF/Net Income
LMAT	34.1%	30.9%	3.2%	139.9%
ANN	11.7%	8.3%	3.4%	173.5%
FPH	28.4%	21.0%	7.4%	141.7%
RMD	34.2%	31.7%	2.5%	124.8%
CTEC	19.1%	14.1%	4.9%	265.8%
EL	18.6%	13.2%	5.4%	228.6%
Industry median	13.8%	8.6%	3.8%	128.3%

Company	CF Margin	FCF Margin	CapEx Ratio	CF/Net Income
LMAT	34.1%	30.9%	3.2%	139.9%
XRAY	7.3%	2.8%	4.5%	-42.7%
PLSE	-7,349.7%	-7,390.0%	40.3%	74.0%
ATRC	11.7%	9.7%	3.2%	-1,401.3%
WRBY	11.9%	4.4%	7.5%	7,870.6%
ICUI	7.8%	3.7%	4.0%	361.3%
Industry median	13.8%	8.6%	3.8%	128.3%

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on LMAT

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 6, 26. This content is for informational purposes only and is not investment advice.